New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
J Ethnopharmacol. 2022 Feb 10;284:114760. doi: 10.1016/j.jep.2021.114760. Epub 2021 Oct 19.
Traditional Chinese medicines (TCMs) have made great contributions to the prevention and treatment of human diseases in China, and especially in cases of COVID-19. However, due to quality problems, the lack of standards, and the diversity of dosage forms, adverse reactions to TCMs often occur. Moreover, the composition of TCMs makes them extremely challenging to extract and isolate, complicating studies of toxicity mechanisms.
The aim of this paper is therefore to summarize the advanced applications of mass spectrometry imaging (MSI) technology in the quality control, safety evaluations, and determination of toxicity mechanisms of TCMs.
Relevant studies from the literature have been collected from scientific databases, such as "PubMed", "Scifinder", "Elsevier", "Google Scholar" using the keywords "MSI", "traditional Chinese medicines", "quality control", "metabolomics", and "mechanism".
MSI is a new analytical imaging technology that can detect and image the metabolic changes of multiple components of TCMs in plants and animals in a high throughput manner. Compared to other chemical analysis methods, such as liquid chromatography-mass spectrometry (LC-MS), this method does not require the complex extraction and separation of TCMs, and is fast, has high sensitivity, is label-free, and can be performed in high-throughput. Combined with chemometrics methods, MSI can be quickly and easily used for quality screening of TCMs. In addition, this technology can be used to further focus on potential biomarkers and explore the therapeutic/toxic mechanisms of TCMs.
As a new type of analysis method, MSI has unique advantages to metabolic analysis, quality control, and mechanisms of action explorations of TCMs, and contributes to the establishment of quality standards to explore the safety and toxicology of TCMs.
中药(TCM)在中国对人类疾病的预防和治疗做出了巨大贡献,尤其是在 COVID-19 方面。然而,由于质量问题、缺乏标准以及剂型多样性,TCM 经常会出现不良反应。此外,TCM 的组成使得它们极难提取和分离,这使得毒性机制的研究变得复杂。
本文的目的是总结质谱成像(MSI)技术在中药质量控制、安全性评价和毒性机制研究中的应用。
从科学数据库(如“PubMed”、“Scifinder”、“Elsevier”、“Google Scholar”)中收集了有关文献中的相关研究,使用的关键词是“MSI”、“传统中药”、“质量控制”、“代谢组学”和“机制”。
MSI 是一种新的分析成像技术,可高通量检测和成像动植物 TCM 中多种成分的代谢变化。与其他化学分析方法(如液相色谱-质谱联用(LC-MS))相比,该方法不需要对 TCM 进行复杂的提取和分离,速度快、灵敏度高、无需标记且可进行高通量分析。与化学计量学方法相结合,MSI 可快速、轻松地用于 TCM 的质量筛选。此外,该技术可进一步关注潜在的生物标志物,并探索 TCM 的治疗/毒性机制。
作为一种新型分析方法,MSI 对 TCM 的代谢分析、质量控制和作用机制探索具有独特的优势,有助于建立质量标准,探索 TCM 的安全性和毒理学。